pHAGE N-mRuby3 (from SARS-CoV-2) IRES puro Citations (2)

Originally described in: Pharmacological perturbation of intracellular dynamics as a SARS-CoV-2 antiviral strategy
Bakhache W, Partiot E, Lucansky V, Bare Y, BonaventurB V, Goujon C, Bories C, Deffieu M.S, Gaudin R bioRxiv 2021 Journal

---

Articles Citing pHAGE N-mRuby3 (from SARS-CoV-2) IRES puro

Articles
Delivery of Antibody-Like Molecules, Monobodies, Capable of Binding with SARS-CoV-2 Virus Nucleocapsid Protein, into Target Cells. Khramtsov YV, Ulasov AV, Lupanova TN, Georgiev GP, Sobolev AS. Dokl Biochem Biophys. 2022 Oct;506(1):220-222. doi: 10.1134/S1607672922050088. Epub 2022 Oct 27. PubMed
Intracellular Degradation of SARS-CoV-2 N-Protein Caused by Modular Nanotransporters Containing Anti-N-Protein Monobody and a Sequence That Recruits the Keap1 E3 Ligase. Khramtsov YV, Ulasov AV, Lupanova TN, Slastnikova TA, Rosenkranz AA, Bunin ES, Georgiev GP, Sobolev AS. Pharmaceutics. 2023 Dec 19;16(1):4. doi: 10.3390/pharmaceutics16010004. PubMed

If you have published an article using this material, please email us at to have your article added to this page.